MDT

99.36

+1.42%↑

A

146.53

+0.24%↑

VEEV

219.29

+0.75%↑

HQY

88.47

+3.78%↑

NEOG

9.51

+3.71%↑

MDT

99.36

+1.42%↑

A

146.53

+0.24%↑

VEEV

219.29

+0.75%↑

HQY

88.47

+3.78%↑

NEOG

9.51

+3.71%↑

MDT

99.36

+1.42%↑

A

146.53

+0.24%↑

VEEV

219.29

+0.75%↑

HQY

88.47

+3.78%↑

NEOG

9.51

+3.71%↑

MDT

99.36

+1.42%↑

A

146.53

+0.24%↑

VEEV

219.29

+0.75%↑

HQY

88.47

+3.78%↑

NEOG

9.51

+3.71%↑

MDT

99.36

+1.42%↑

A

146.53

+0.24%↑

VEEV

219.29

+0.75%↑

HQY

88.47

+3.78%↑

NEOG

9.51

+3.71%↑

Search

Inspire Medical Systems Inc

Abrir

SetorSaúde

97.2 5.88

Visão Geral

Variação de preço das ações

24h

Atual

Mín

91.37

Máximo

96.66

Indicadores-chave

By Trading Economics

Rendimento

14M

9.9M

Vendas

7.4M

225M

P/E

Médio do Setor

66.39

90.831

Margem de lucro

4.424

Funcionários

1,246

EBITDA

16M

17M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+58.3% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

687M

2.9B

Abertura anterior

91.32

Fecho anterior

97.2

Sentimento de Notícias

By Acuity

33%

67%

68 / 361 Ranking em Healthcare

Inspire Medical Systems Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de jan. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 de jan. de 2026, 00:00 UTC

Ganhos

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 de jan. de 2026, 23:47 UTC

Conversa de Mercado

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 de jan. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 de jan. de 2026, 23:39 UTC

Conversa de Mercado

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 de jan. de 2026, 23:32 UTC

Conversa de Mercado

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 de jan. de 2026, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 de jan. de 2026, 22:53 UTC

Aquisições, Fusões, Aquisições de Empresas

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 de jan. de 2026, 22:17 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

14 de jan. de 2026, 22:17 UTC

Conversa de Mercado

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 de jan. de 2026, 22:09 UTC

Ganhos

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 de jan. de 2026, 22:08 UTC

Ganhos

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 de jan. de 2026, 22:08 UTC

Ganhos

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 de jan. de 2026, 21:53 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 de jan. de 2026, 21:53 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 de jan. de 2026, 21:52 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Announces Positive Profit Alert for 2025

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Citigroup Acting as Financial Advisor to WuXi XDC

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

14 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

14 de jan. de 2026, 21:49 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 de jan. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 de jan. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Makes Cash Offer for BioDlink International

14 de jan. de 2026, 21:13 UTC

Conversa de Mercado

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 de jan. de 2026, 20:30 UTC

Conversa de Mercado
Ganhos

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 de jan. de 2026, 20:13 UTC

Conversa de Mercado

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 de jan. de 2026, 20:08 UTC

Conversa de Mercado

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 de jan. de 2026, 19:33 UTC

Conversa de Mercado

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 de jan. de 2026, 19:06 UTC

Conversa de Mercado
Ganhos

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparação entre Pares

Variação de preço

Inspire Medical Systems Inc Previsão

Preço-alvo

By TipRanks

58.3% parte superior

Previsão para 12 meses

Média 146.36 USD  58.3%

Máximo 180 USD

Mínimo 91 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para Inspire Medical Systems Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

18 ratings

13

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

68 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat